States that have recently cut or restricted GLP-1 coverage for weight loss include: North Carolina (ended coverage October 2025) California, New Hampshire, and South Carolina (ending coverage January 2026) Pennsylvania (restricting coverage to non-weight-loss indications) Michigan (limiting to morbidly obese patients only) The BALANCE model will open to state Medicaid agencies as early as May 2026, which could eventually bring more uniform pricing and access
Do not fight it
For researchers seeking a peptide which may provide a tanned appearance without harmful UV exposure, alongside the potential for sexual enhancement and improved body composition, Melanotan II offers a compelling, multi-targeted option to consider
Gene expression profiling revealed distinct apoptotic pathways: low-dose exposure triggers apoptosis through cellular stress responses, while high-dose exposure primarily activates it via direct DNA damage (160)
Contamination, mislabeling, and immunogenicity risks are not theoretical in this supply chain
Read more in our editorial policy